Asmo Generics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 97.88%
- Ebitda 73.72%
- Net Worth -1.67%
- Total Assets -0.20%
About Asmo Generics
Asmo Generics Private Limited (AGPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2019 (Six years 30 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhagwan Pawar, Krithika Jain, and Ashok Chhajed serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110MH2019PTC320162
- Company No.
320162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Asmo Generics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagwan Pawar  | Director | 25-Jan-2019 | Current |
| Krithika Jain | Director | 25-Jan-2019 | Current |
| Ashok Chhajed | Director | 24-Jun-2019 | Current |
Financial Performance of Asmo Generics.
Asmo Generics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.88% increase in profit. The company's net worth dipped by a decrease of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asmo Generics?
Unlock access to Asmo Generics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Datasolcafe Private LimitedBhagwan Pawar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asmo Generics?
Unlock and access historical data on people associated with Asmo Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asmo Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asmo Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.